Increase in multiple sclerosis activity after assisted reproduction technology

Annals of Neurology

Volumn 72, Issue 5, 2012, Pages 682-694

  Correale, Jorge ^a   Farez, Mauricio F ^a   Ysrraelit, María C ^a  

^a FLENI   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; CD19 ANTIGEN; CD4 ANTIGEN; ESTRADIOL; GADOLINIUM PENTETATE; GAMMA INTERFERON; GONADORELIN AGONIST; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 8; METHYLPREDNISOLONE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PREDNISONE; PROTEIN BCL 2; RECOMBINANT FOLLITROPIN; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; BLOOD BRAIN BARRIER; CD4+ T LYMPHOCYTE; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ACTIVITY; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; IMMUNOLOGY TEST KIT; INFERTILITY THERAPY; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; T CELL DEPLETION; TREATMENT DURATION;

ADULT; ANTIBODIES; B-CELL ACTIVATING FACTOR; BRAIN; CASE-CONTROL STUDIES; CELL MOVEMENT; CYTOKINES; DISABILITY EVALUATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFERTILITY; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEIN; PROTO-ONCOGENE PROTEINS C-BCL-2; RECURRENCE; REPRODUCTIVE TECHNIQUES, ASSISTED; RETROSPECTIVE STUDIES; RNA, SMALL INTERFERING; T-LYMPHOCYTES; TIME FACTORS; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84871998751     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23745     Document Type: Article

References (53)

1. Compston A, Coles A,. Multiple sclerosis. Lancet 2008; 372: 1502-1517.
2. Antel J, Bar-Or A,. Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment. J Neuroimmunol 2006; 180: 3-8. (Pubitemid 44692323)
3. Genain CP, Nguyen MH, Letvin NL, et al. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J Clin Invest 1995; 96: 2966-2974.
4. Litzenburger T, Fässler R, Bauer J, et al. B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J Exp Med 1998; 188: 169-180. (Pubitemid 28328615)
5. Jagessar SA, Smith PA, Blezer E, et al. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets. J Neuropathol Exp Neurol 2008; 67: 326-340. (Pubitemid 351507488)
6. Costa M, Colia D,. Treating infertility in autoimmune patients. Rheumatology (Oxford) 2008; 47 (suppl 3): iii38-iii41.
7. Ferrero S, Pretta S, Ragni N,. Multiple sclerosis: management issues during pregnancy. Eur J Obstet Gynecol Reprod Biol 2004; 115: 3-9. (Pubitemid 38844209)
8. González DA, Díaz BB, Rodríguez Pérez MDC, et al. Sex hormones and autoimmunity. Immunol Lett 2010; 133: 6-13.
9. Jacobson JD, Nisula BC, Steinberg AD,. Modulation of the expression of murine lupus by gonadotropin-releasing hormone analogs. Endocrinology 1994; 134: 2516-2523. (Pubitemid 24170865)
10. Laplaud D-A, Leray E, Barrière P, et al. Increase in multiple sclerosis relapse rate following in vitro fertilization. Neurology 2006; 66: 1280-1281. (Pubitemid 43739727)
11. Hellwig K, Beste C, Brune N, et al. Increased MS relapse rate during assisted reproduction technique. J Neurol 2008; 255: 592-593.
12. Hellwig K, Schimrigk S, Beste C, et al. Increase in relapse rate during assisted reproduction technique in patients with multiple sclerosis. Eur Neurol 2009; 61: 65-68.
13. Michel L, Foucher Y, Vukusic S, et al. Increased risk of multiple sclerosis relapse after in vitro fertilization. J Neurol Neurosurg Psychiatry 2012; 83: 796-802.
14. Correale J, Rush C, Amengual A, Goicochea MT,. Mitoxantrone as rescue therapy in worsening relapsing-remitting MS patients receiving IFN-β. J Neuroimmunol 2005; 162: 173-183.
15. Correale J, McMillan M, McCarthy K, et al. Isolation and characterization of autoreactive proteolipid protein-peptide specific T-cell clones from multiple sclerosis patients. Neurology 1995; 45: 1370-1378.
16. Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS,. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci U S A 1986; 83: 2496-2500. (Pubitemid 16026909)
17. Alter A, Duddy M, Hebert S, et al. Determinants of human B cell migration across brain endothelial cells. J Immunol 2003; 170: 4497-4505. (Pubitemid 36522744)
18. Whitaker HJ, Hocine MN, Farrington CP,. The methodology of self-controlled case series studies. Stat Methods Med Res 2009; 18: 7-26.
19. Hocine MN, Farrington CP, Touzé E, et al. Hepatitis B vaccination and first central nervous system demyelinating events: reanalysis of a case-control study using the self-controlled case series method. Vaccine 2007; 25: 5938-5943. (Pubitemid 47043220)
20. Farez MF, Ysrraelit MC, Fiol M, Correale J,. H1N1 vaccination does not increase risk of relapse in multiple sclerosis: A self-controlled case-series study. Mult Scler 2012; 18: 254-256.
21. Chen A, Ganor Y, Rahimipour S, et al. The neuropeptides GnRH-II and GnRH-I are produced by human T cells and trigger laminin receptor gene expression, adhesion, chemotaxis and homing to specific organs. Nat Med 2002; 8: 1421-1426. (Pubitemid 36019427)
22. Wu TJ, Glucksman MJ, Roberts JL, Mani SK,. Facilitation of lordosis in rats by a metabolite of luteinizing hormone releasing hormone. Endocrinology 2006; 147: 2544-2549.
23. Confavreux C, Hutchinson M, Hours MM, et al. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 1998; 339: 285-291. (Pubitemid 28366416)
24. Straub RH,. The complex role of estrogens in inflammation. Endocr Rev 2007; 28: 521-574. (Pubitemid 47236336)
25. Langer-Gould A, Gupta R, Huang S, et al. Interferon-γ-producing cells, pregnancy and post partum relapses of multiple sclerosis. Arch Neurol 2010; 67: 51-57.
26. Chen HF, Jeung EB, Stephenson M, Leung PC,. Human peripheral blood mononuclear cells express gonadotropin-releasing hormone (GnRH), GnRH receptor, and interleukin-2 receptor gamma-chain messenger ribonucleic acids that are regulated by GnRH in vitro. J Clin Endocrinol Metab 1999; 84: 743-750. (Pubitemid 29075715)
27. Batticane N, Morale MC, Gallo F, et al. Luteinizing hormone-releasing hormone signaling at the lymphocyte involves stimulation of interleukin-2 receptor expression. Endocrinology 1991; 129: 277-286.
28. Grasso G, Massai L, De Leo V, Muscettola M,. The effect of LHRH and TRH on human interferon-gamma production in vivo and in vitro. Life Sci 1998; 62: 2005-2014. (Pubitemid 28239713)
29. Cavanagh PC, Dunk C, Pampillo M, et al. Gonadotropin-releasing hormone-regulated chemokine expression in human placentation. Am J Physiol Cell Physiol 2009; 297: C17-C27.
30. Huss DJ, Winger RC, Peng H, et al. TGF-β enhances effector Th1 cells activation but promotes self regulation via IL-10. J Immunol 2010; 184: 5628-5636.
31. Correale J, Arias M, Gilmore W,. Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1998; 161: 3365-3374.
32. Gilmore W, Weiner LP, Correale J,. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1997; 158: 446-451. (Pubitemid 127483887)
33. Walker SE,. Estrogen and autoimmune disease. Clin Rev Allergy Immunol 2011; 40: 60-65.
34. Cutolo M, Capellino S, Straub RH,. Oestrogens in rheumatic diseases: friend or foe? Rheumatology (Oxford) 2008; 47 (suppl 3): iii2-iii5.
35. Voskuhl RR, Pitchekian-Halabi H, MacKenzie-Graham A, et al. Gender differences in autoimmune demyelination in the mouse: implications for multiple sclerosis. Ann Neurol 1996; 39: 724-733. (Pubitemid 26183808)
36. Olsen NJ, Kovacs WJ,. Gonadal steroids and immunity. Endocr Rev 1996; 17: 369-384. (Pubitemid 26277980)
37. Kim S, Liva SM, Dalal MA, et al. Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis. Neurology 1999; 52: 1230-1238. (Pubitemid 29177927)
38. Polanczyk M, Zamora A, Subramanian S, et al. The protective effect of 17beta-estradiol on experimental autoimmune encephalomyelitis is mediated through estrogen receptor-alpha. Am J Pathol 2003; 163: 1599-1605. (Pubitemid 37175106)
39. Sicotte NL, Liva SM, Klutch R, et al. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 2002; 52: 421-428.
40. Ietta F, Bechi N, Romagnoli R, et al. 17 beta-Estradiol modulates the macrophage migration inhibitory factor secretory pathway by regulating ABCA1 expression in human first-trimester placenta. Am J Physiol Endocrinol Metab 2010; 298: E411-E418.
41. Verthelyi D, Ansar Ahmed S,. Characterization of estrogen-induced autoantibodies to cardiolipin in non-autoimmune mice. J Autoimmun 1997; 10: 115-125. (Pubitemid 27242452)
42. Beagley KW, Gockel CM,. Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol Med Microbiol 2003; 38: 13-22. (Pubitemid 37297438)
43. Venkatesh J, Peeva E, Xu X, Diamond B,. Cutting Edge: Hormonal milieu, not antigenic specificity, determines the mature phenotype of autoreactive B cells. J Immunol 2006; 176: 3311-3314. (Pubitemid 43363976)
44. Bynoe MS, Grimaldi CM, Diamond B,. Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells. Proc Natl Acad Sci U S A 2000; 97: 2703-2708. (Pubitemid 30159235)
45. Giunti D, Borsellino G, Benelli R, et al. Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. J Leukoc Biol 2003; 73: 584-590. (Pubitemid 38040470)
46. Krumbholz M, Theil D, Cepok S, et al. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 2006; 129 (pt 1): 200-211. (Pubitemid 43063771)
47. Lund BT, Ashikian N, Ta HQ, et al. Increased CXCL8 (IL-8) expression in multiple sclerosis. J Neuroimmunol 2004; 155: 161-171. (Pubitemid 39165789)
48. Müller Ladner U, Jones JL, Wetsel RA, et al. Enhanced expression of chemotactic receptors in multiple sclerosis lesions. J Neurol Sci 1996; 144: 135-141. (Pubitemid 27019169)
49. Argaw AT, Gurfein BT, Zhang Y, et al. VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci U S A 2009; 106: 1977-1982.
50. Proescholdt MA, Jacobson S, Tresser N, et al. Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J Neuropathol Exp Neurol 2002; 61: 914-925.
51. Zhu C-S, Hu X-Q, Xiong Z-J, et al. Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) inhibits experimental autoimmune encephalomyelitis in dark agouti (DA) rats. Life Sci 2008; 83: 404-412.
52. Buljevac D, Hop WC, Reedeker W, et al. Self reported stressful life events and exacerbations in multiple sclerosis: prospective study. BMJ 2003; 327: 646.
53. Mohr DC, Goodkin DE, Bacchetti P, et al. Psychological stress and the subsequent appearance of new brain MRI lesions in MS. Neurology 2000; 55: 55-61. (Pubitemid 30460998)